Renal impairment is caused by nephropathy and nephrotoxicity, both of which have a major impact on the world's healthcare system. Numerous kidney disorders, each with unique pathophysiological mechanisms and clinical presentations, are included in the category of nephropathy. These include glomerulonephritis, diabetic nephropathy, hypertensive nephropathy, and polycystic kidney disease. To investigate the viewpoints of haemodialysis patients, a qualitative methodology was employed. An metropolitan teaching hospital's outpatient haemodialysis clinic served as the site of one-on-one, in-person, semi-structured interviews. Relying mainly on biomarkers for disease diagnosis and monitoring, accurate assessment of chronic kidney disease (CKD) in older adults is vital for prompt intervention and therapy. Systemic inflammation, metabolic alterations, and drug use are widespread within this populace and can drastically modify biomarkers such serum creatinine, estimated glomerular filtration rate and albuminuria. On the other hand early innovators like Willem Kolff and Belding Scribner developed dialysis, which led to a number of significant shifts in the economics, epidemiology, and morality of renal failure treatment. But even though dialysis services, especially haemodialysis, have rapidly expanded, especially in nations with high incomes, genuine focused on patients advancement is moving more slowly now. Similar to haemodialysis, cardiovascular events account for over half of all PD deaths, and there is a lot of interest in figuring out what modality-specific factors lead to these events. Important discoveries emphasize the significance of averting nephrotoxic substances associated with medical and environmental settings, the necessity of careful monitoring of renal function, and the significance of early diagnosis by biomarkers.